119 filings
Page 5 of 6
8-K
0in6 3c84
17 Mar 20
Entry into a Material Definitive Agreement
4:52pm
8-K
tykhyszwxdu3w
12 Mar 20
X4 Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2019 Financial Results
7:36am
8-K
mj73w6d5ary0r2vbgim
13 Feb 20
Departure of Directors or Certain Officers
4:18pm
8-K
uufsjlmum3pt7l0x
10 Jan 20
Results of Operations and Financial Condition
4:00pm
8-K
my1h7mae
27 Nov 19
X4 Pharmaceuticals Announces Proposed Public Offering of Common Stock and Class B Warrants
5:18pm
8-K
rprps
14 Nov 19
Entry into a Material Definitive Agreement
4:05pm
8-K
96jd946f b7
7 Nov 19
X4 Pharmaceuticals Reports Third Quarter 2019 Financial Results and Recent Business Highlights
7:10am
8-K/A
dkauay2ok09epa 8md1e
18 Oct 19
Departure of Directors or Certain Officers
4:31pm
8-K
tb4qz1
4 Oct 19
Regulation FD Disclosure
5:08pm
8-K
ldyjpub
30 Sep 19
Subgroup exceeds target of 50% improvement in median progression-free survival
7:21am
8-K
r2ldn
20 Sep 19
Departure of Directors or Certain Officers
4:16pm
8-K
yy59rk9x
9 Aug 19
Other Events
6:06am
8-K
2k19d
28 Jun 19
Entry into a Material Definitive Agreement
8:30am
8-K
1mq 9mcqkw
26 Jun 19
Other Events
8:44am
8-K
y6s3 1vuoedjxhtqzjz
19 Jun 19
Departure of Directors or Certain Officers
4:45pm
8-K/A
5gojb c7j
17 May 19
Departure of Directors or Certain Officers
4:12pm
8-K/A
yieordi 1kkz9i6wzd
13 May 19
Financial Statements and Exhibits
4:58pm
8-K
mb0xn
15 Apr 19
X4 Pharmaceuticals Prices $85.8 Million Public Offering of Common Stock and Class A Warrants
4:41pm
8-K
ze4 kl1wbu07hi1cai66
12 Apr 19
X4 Pharmaceuticals Announces Proposed Public Offering of Common Stock and Class A Warrants
6:08am
8-K
4p70frngjzppkexi
11 Apr 19
Other Events
4:00pm